
Risek®
Therapeutic Segment:
Anti-Ulcerant, Gastric acid suppressant
Generic Name:
Omeprazole
Indication
Capsules
- 20MG
- 40MG
Injectable
- 40MG
Capsules
For the treatment of:
- Gastro-Esophageal Reflux Disease (GERD).
- Gastric and duodenal ulcer.
- Treatment and prophylaxis of NSAID-associated ulceration.
- Eradication of Helicobacter pylori infection associated with peptic ulcer disease.
- Zollinger-Ellison Syndrome.
- Dyspepsia.
- Prophylaxis of acid aspiration.
Injectable
For patients who are unable to take oral therapy for the short-term (upto 5 days) treatment of:
- Gastro-esophageal reflux disease.
- Peptic ulcer disease.
- Treatment and prophylaxis of NSAID-associated ulceration.
- Duodenal ulcer.
- Zollinger-Ellison syndrome.
- Prophylaxis of acid aspiration.